logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Transplantation and Cellular Therapy cover

Transplantation and Cellular Therapy

IF4.4
Papers2182
Citations4360
Journal Papers 2191
Publication Date
delete
Lineage Plasticity–Mediated Resistance to CD7-Directed CAR-T Therapy in Relapsed/Refractory T-ALL/LBL
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-29
delete0
PREAI
deleteJiahua Niu; Kun Wang; Shizhen Qiu; Fang Xiang; Huiying Qiu; Xueying Ding; Chongmei Huang; Jun Yang; Yin Tong; Yu Cai; Liping Wan; Kun Zhou; Jingwei Jiang; Baoxia Dong; Haopeng Wang; Xianmin Song
deleteShare
deleteSave
Prophylaxis with dexamethasone or anakinra in patients with high-risk large B cell lymphoma treated with axicabtagene ciloleucel
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-27
delete0
PREAI
deleteRawan G. Faramand; M Bakri Hammami; Christina Bachmeier; Julio C. Chavez; Xuefeng Wang; Bijal Shah; Marian Dam; Aleksandr Lazaryan; Sayeef Mirza; Sameh Gaballa; Farhad Khimani; Hien Liu; Taiga Nishihori; Marco L. Davila; Frederick L. Locke; Michael D. Jain
deleteShare
deleteSave
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-26
delete0
PREAI
deleteDavide Murgia; Federico Lussana; Alessandro Rambaldi; Anna Grassi
deleteShare
deleteSave
Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: A Target Trial Emulation
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-26
delete0
deleteOAAI
deleteMohammed Zuber; Chia Jie Tan; Joshua Caballero; Payaningal R. Somanath; Amandeep Godara; Shaimaa Elshafie; Lorenzo Villa Zapata
deleteShare
deleteSave
Cytokine follow-up complements CAR-HEMATOTOX score to predict severe cytopenia in B-cell malignancies treated with CAR T cells
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-25
delete0
deleteOAAI
deleteJulien Fadel; Caroline Poli; Jérôme Paillassa; Valérie Seegers; Sylvain Thépot; Hubert Rambaud; Franck Geneviève; Valérie Ugo; Mathilde Hunault-Berger; Aline Schmidt-Tanguy; Céline Beauvillain
deleteShare
deleteSave
Child Opportunity Index and Survival After Pediatric Hematopoietic Cell Transplantation for Acute Leukemia
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-24
delete0
PREAI
deleteKatherine T. Lind; Cheng-Chang Wu; Andrew G. Nicklawsky; Danielle Pham; Peyton Bendis; Iwalola Awoyinka; Colleen A. Kelly; Michael R. Verneris; Jennifer M. Knight; Kira Bona
deleteShare
deleteSave
Corrigendum to <Long-Term Follow-Up of CD19 CAR-T for R/R B-NHL: Ki-67 as a Prognostic Factor for Sustained Remission> <[Transplantation and cellular therapy, 32(8), 952.e1–952.e15.]>
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-24
delete0
deleteOAAI
deleteYinghui Yu; Wenxin Wang; Zhuomao Mo; Yuanyin Teng; Mingming Zhang; Dongrui Wang; Shan Fu; Jiazhen Cui; Simao Huang; He Huang; Yongxian Hu; Guoqing Wei
deleteShare
deleteSave
Trends and Predictors of Hematopoietic Cell Transplant Utilization for HIV-lymphoma in California, 1991-2016
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-22
delete0
PREAI
deleteKurt A. David; Ann Brunson; Alex J. Fauer; Sara J. Schonfeld; Shuai Chen; Roland Zepf; Laura Fejerman; Christa Meyer; Jeffery J. Auletta; Lori Muffly; Lindsay M. Morton; Sheryl L. Catz; Theresa H.M. Keegan
deleteShare
deleteSave
Duration of Cryopreservation of Third-Party Viral Specific T-Cells (TP-VSTs) Does Not Influence Clinical Efficacy
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-22
delete0
PREAI
deleteSarah McCormack-Spivey; Jamie Wilhelm; Sachie Ikegami; Zahra Hudda; Ruby Khoury; Stella M Davies; Michael Grimley; Jeremy D Rubinstein
deleteShare
deleteSave
Early Broad-Spectrum Antibiotic Exposure Is Associated with Increased Relapse after Myeloablative TBI-Based Allogeneic Hematopoietic Cell Transplantation
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-21
delete0
deleteOAAI
deleteIsabella Gruber; Matthias Edinger; Hendrik Poeck; Elisabeth Meedt; Ernst Holler; Wolfgang Herr; Oliver Koelbl; Daniel Wolff; Daniela Weber
deleteShare
deleteSave
Prognostic Associations of Molecular MRD and Genomic Features in ZNF384-Rearranged B-ALL Undergoing Allo-HSCT
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-20
delete0
PREAI
deleteXue-Shuang Zhang; Yan-Li Zhao; Jian-Ping Zhang; Min Xiong; Xing-Yu Cao; De-Yan Liu; Rui-Juan Sun; Zhi-Jie Wei; Jia-Rui Zhou; Jing Long; Yue Lu
deleteShare
deleteSave
Differences in Hematopoietic Cell Transplantation Outcomes by HIV status, California, 1991-2016
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-18
delete0
PREAI
deleteKurt A. David; Ann Brunson; Sara J. Schonfeld; Alex J. Fauer; Shuai Chen; Roland Zepf; Laura Fejerman; Christa Meyer; Jeffery J. Auletta; Lori Muffly; Lindsay M. Morton; Sheryl L. Catz; Theresa H.M. Keegan
deleteShare
deleteSave
Comment on “Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma”
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-18
delete0
PREAI
deleteDr. Danti Joseph
deleteShare
deleteSave
Impact of a pharmacist-driven survivorship clinic on adherence to screening and preventive care after allogeneic hematopoietic cell transplant
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-17
delete0
PREAI
deleteKelsea Seago; Autumn Smith; Spencer K. Yingling; Megan Dillaman; Lauren Veltri; Aaron Cumpston
deleteShare
deleteSave
Response to the Letter regarding “Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma”
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-17
delete0
PREAI
deleteTomoyasu Jo
deleteShare
deleteSave
Conversion from calcineurin inhibitor to ruxolitinib as GVHD prophylaxis during patients with transplant-associated thrombotic microangiopathy
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-16
delete0
PREAI
deleteYan Zhang; Hanyin Liang; Zhiping Fan; Huiqing He; Zhi Liu; Fen Huang; Li Xuan; Ren Lin; Xiaofang Li; Jing Sun; Qifa Liu; Na Xu
deleteShare
deleteSave
Incidence rates of immune-related adverse events and their correlation with response in hematological malignancies treated with Chimeric Antigen Receptor T-Cells
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-16
delete0
PREAI
deleteZihao Li; Wuyuan Tan; Shaorong Lei; Yingying Xiao; Yuming Sun
deleteShare
deleteSave
Effect of mesenchymal stem cells on peripheral immune cells in multiple sclerosis: results from an international phase 2 clinical trial
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-15
delete0
PREAI
deleteIrene Schiavetti; Mark S. Freedman; Simon Thebault; Federico Ivaldi; Serena Palmeri; Roberto Furlan; Antonio Uccelli; Alice Laroni
deleteShare
deleteSave
The Critical Therapeutic Window Lies Before Intubation: HFNC and Mortality Across Ventilatory Escalation Tiers in Pediatric HSCT
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-11
delete0
deleteOAAI
deleteMichael Merker; Eliana Weiß; Roland Schrewe; Verena Dries; Jan-Henning Klusmann; Peter Bader; Eva Rettinger
deleteShare
deleteSave
Integrated analysis of hematopoietic changes following heterochronic bone marrow transplantation between young and aged mice
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-09-11
delete0
deleteOAAI
deleteJosé Antonio Bejarano-García; Melanie Nufer; Rocío Caracuel; Teresa Caballero-Velázquez; Alfonso Rodríguez Gil; Alicia Jordano; Raquel Muñoz; José Ignacio Piruat; José Antonio Pérez-Simón
deleteShare
deleteSave